Zhao Chuan-Sheng, Hartikainen Sirpa, Schallert Timothy, Sivenius Juhani, Jolkkonen Jukka
Department of Neurology, University of Kuopio, Kuopio, Finland.
Neurosci Biobehav Rev. 2008;32(1):56-71. doi: 10.1016/j.neubiorev.2007.05.003. Epub 2007 May 24.
The recovery process following cerebral insults such as stroke is affected by aging and pharmacotherapy. The use of medication including CNS-active drugs has increased in the elderly during recent years. However, surprisingly little is known about how safe they are with respect to severity of sensorimotor and cognitive impairments or recovery of function following possible cerebrovascular accidents. This review examines the experimental and clinical literature, primarily from 1995 onwards, concerning medication in relation to cerebrovascular events and functional recovery. Special attention is directed to polypharmacy and to new CNS-active drugs, which the elderly are already taking or are prescribed to treat emerging, stroke-induced psychiatric symptoms. The neurobiological mechanisms affected by these drugs are discussed.
